Suppr超能文献

指南指导药物的处方率与日本急性心肌梗死患者住院死亡率相关:来自 JROAD-DPC 研究的报告。

Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.

机构信息

1 National Cerebral and Cardiovascular Center Suita Japan.

2 Hokkaido University Graduate School of Medicine Hokkaido Japan.

出版信息

J Am Heart Assoc. 2019 Apr 2;8(7):e009692. doi: 10.1161/JAHA.118.009692.

Abstract

Background The JROAD-DPC (Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination) is a nationwide claims database comprised of the Japanese DPC /Per Diem Payment System. This study aimed to investigate the relationship between prescription rates of guideline-directed medications in each hospital and in-hospital mortality among patients with acute myocardial infarction. Methods and Results A total of 61 838 Japanese patients from 741 hospitals with acute myocardial infarction between 2012 and 2013 were enrolled. The relationship between prescription rates of 4 guideline-directed medications for acute myocardial infarction and in-hospital mortality was analyzed. There were variations in the prescription ratio of β-blockers on admission (median prescription rate 23% [interquartile range 11% to 38%]) and at discharge (51% [36% to 63%]), and of angiotensin converting enzyme/receptor blocker (60% [47% to 70%]). The highest prescription rate quartile of each medication was associated with a significantly lower mortality compared with the lowest prescription rate quartile (aspirin on admission, incidence rate ratio 0.67 [95% CI 0.61-0.74], P<0.001; aspirin at discharge, incidence rate ratio 0.50 [95% CI 0.46-0.55], P<0.001; β-blocker on admission, 0.83 [0.76-0.92], P<0.001; β-blocker at discharge, 0.78 [0.71-0.85], P<0.001; angiotensin converting enzyme/receptor blocker, 0.68 [0.62-0.75], P<0.001; statin, 0.63 [0.57-0.70], P<0.001). The composite prescription score was inversely associated with in-hospital mortality (β coefficient=-0.48, P<0.001) and was closer to the plateau in the high-score range (median mortality for composite prescription scores of 6, 15, and 24 were 10.6%, 6.8%, and 4.6%, respectively). Conclusions The prescription rates of guideline-directed medications for treatment of Japanese acute myocardial infarction patients were inversely associated with in-hospital mortality.

摘要

背景

JROAD-DPC(日本所有心血管疾病诊断程序组合登记处)是一个由日本 DPC/按日付费系统组成的全国性索赔数据库。本研究旨在探讨每家医院指南指导药物的处方率与急性心肌梗死患者院内死亡率之间的关系。

方法

本研究纳入了 2012 年至 2013 年期间来自 741 家医院的 61838 名急性心肌梗死日本患者。分析了 4 种急性心肌梗死指南指导药物的处方率与院内死亡率之间的关系。入院时β受体阻滞剂的处方率(中位数处方率 23%[11%至 38%])和出院时β受体阻滞剂的处方率(51%[36%至 63%])以及血管紧张素转换酶/受体阻滞剂(60%[47%至 70%])存在差异。每种药物的最高处方率四分位数与最低处方率四分位数相比,死亡率显著降低(入院时阿司匹林,发病率比 0.67[95%可信区间 0.61-0.74],P<0.001;出院时阿司匹林,发病率比 0.50[95%可信区间 0.46-0.55],P<0.001;入院时β受体阻滞剂,0.83[0.76-0.92],P<0.001;出院时β受体阻滞剂,0.78[0.71-0.85],P<0.001;血管紧张素转换酶/受体阻滞剂,0.68[0.62-0.75],P<0.001;他汀类药物,0.63[0.57-0.70],P<0.001)。复合处方评分与院内死亡率呈负相关(β系数=-0.48,P<0.001),且在高分范围更接近平台(复合处方评分分别为 6、15 和 24 的中位数死亡率分别为 10.6%、6.8%和 4.6%)。

结论

日本急性心肌梗死患者指南指导药物的处方率与院内死亡率呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd97/6509709/cb9576a282c5/JAH3-8-e009692-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验